Speaker Details

John Ingram, PhD, MD

John Ingram, PhD, MD

SESSIONS

S030 A New Paradigm in the Management of the Hidradenitis Suppurativa Disease Spectrum
Mar 28, 2026 • 9:00 AM - 12:00 PM • Mile High 2B

DISCLOSURES

AbbVie – Consultant(Honoraria); Bluefin Biomedicine – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); British Journal of Dermatology – Other(Honoraria); Cantargia – Consultant (1099 relationship)(Honoraria); ChemoCentryx – Consultant(Honoraria); Citryll – Consultant(Honoraria); Elasmogen – Consultant (1099 relationship)(Honoraria); Engitix – Consultant (1099 relationship)(Honoraria); Incyte – Consultant (1099 relationship)(Honoraria); Indero, Inc. – Consultant (1099 relationship)(Honoraria); InflaRx – Consultant (1099 relationship)(Honoraria); Insmed Incorporated – Advisory Board(Honoraria); Kymera Therapeutics – Advisory Board(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Novartis – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); Union Therapeutics – Consultant (1099 relationship)(Honoraria); Viela Bio – Advisory Board(Honoraria);